A new device bends visible light inside a crystal to produce “synchrotron” radiation (blue and green) via an accelerating light pulse (red) on a scale a thousand times smaller than massive facilities around the world.
Purdue University researchers used an MRI to show a play-by-play of how sending an electric impulse to the vagus nerve successfully corrects stomach complications. The technique paves the way for more precise treatment that drugs and dietary changes have not achieved.
Determining the structure of a virus is an important step in understanding and treating viral disease.
Flaviviruses, such as dengue and Zika, were assumed to be symmetrical icosahedrons. But these icosahedral viruses might not be perfectly symmetrical after all, according to a new study.
Purdue startup introduces new, less invasive technology for early detection of diseases using liquid biopsies shown to reduce anxiety, enable faster detection and treatment.
A Purdue University-led team developed a new material and manufacturing process that would make one way to use solar power – as heat energy – more efficient in generating electricity.
The innovation is an important step for putting solar heat-to-electricity generation in direct cost competition with fossil fuels, which generate more than 60 percent of electricity in the U.S.
Construction is underway on the Convergence Center for Innovation and Collaboration in the Discovery Park District and should be completed by December 2019. The 145,000-square-foot, five-story office building will serve as the front door for companies interested in research or business collaborations with Purdue University.
Heart surgery can be traumatic for patients. Having to continuously monitor your status without a doctor when you are back home can be even scarier. Imagine being able to do that with a simple sticker applied to your body.
The Purdue University Quantum Center is investigating how to advance quantum communication for practical uses.
The use of thalidomide by pregnant women resulted in horrific birth defects in more than 10,000 children around the world. Now, Purdue University researchers have developed a new chemical process to find better drug ‘fits’ for patients.
Purdue University researchers are testing whether a simple light-emitting diode array that is safe to use on human skin can be used to inactivate methicillin-resistant Staphylococcus aureus, or MRSA, one of six ‘high priority’ pathogens that the World Health Organization has identified as an imminent threat to public health. Here the light shines above a 96-well plate in a bio-safety hood.